Pre-Exposure Prophylaxis (PrEP) for People Who Inject Drugs


The briefing paper Pre-Exposure Prophylaxis (PrEP) for People Who Inject Drugs: Community Voices on Pros, Cons, and Concerns outlines the results of a global consultation by the International Network of People who Use Drugs on PrEP. Approximately 75 people from 33 different countrires participated in the consultation.

Key findings of INPUD's consultation include:

  1. The promotion of PrEP was seen as unethical and unfeasible when access to treatment for people who inject drugs and are living with HIV is low (between 1-4% in some countries);
  2. The promotion of PrEP was seen as part of a wider, biomedial rhetoric that undermines the provision of community-led programming. There is worry that funding priorities will change and the scarce funding available for community-led programming would be allocated towards biomedical programmes;
  3. The promotion of PrEP was seen as premature, since there is insufficient evidence that PrEP works as effectively to prevent HIV transmission by the sharing of injecting equipment, as it does with other routes of transmission;
  4. The promotion of PrEP does not protect against hepatitis C, infections, and vein damage;
  5. The promotion PrEP does not address the stigma, discrimination, and criminalisation faced by people who inject drugs. Failure to remove these will leave people who inject drugs with the same limited access to services as is currently the case, and finally;
  6. Participants in the consultation expressed concern that PrEP may become mandatory for people who use drugs or that people who use drugs will be coerced to take it.

Contents include:

  • Introduction
  • Methodology
  • Findings
  • Conclusions and Key Messages
  • About INPUD

You can download this 17 page PDF resource above. This resource is in English.